Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-02-24 @ 3:52 AM
Study NCT ID:
NCT02696434
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2016-02-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
Sponsor:
Alkermes, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALK6428-A302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None